Tamiflu Research a Mixed Report

One of my favorite literature researchers is Richard Bukata.
Here he talks about a marginal benefit for flu.
Tamiflu
http://www.epmonthly.com/www.epmonthly.com/features/current-features/tamiflu-know-the-research-before-you-prescribe/?utm_source=EPM+2014-1-23&utm_campaign=EPM+January+23+2014&utm_medium=email

Tamiflu Overrated

Genentech says it can’t keep up with Tamiflu production, and the shortage is reported as a problem. Or is it.
Well, like most crises, it’s not, the benefits are overrated and amount to a reduction in severity or length of the flu at best, and Tamiflu resistance is increasing.
http://www.franchiseherald.com/articles/4616/20140109/tamiflu-flu-medicine-production-issues-delay-childrens-recovery-capsule-form-in-regular-supply.htm